As for the primary outcome, it will be analyzed by comparing the delayed time to the occurrence of CV death, delayed time to the occurrence of the first HF hospitalization event, or a relative change in NT-proBNP from baseline to week 12 [49]. This evidence concerns the gene NPPB and hydrops fetalis.